RE: Unhappy9 Nov 2021 14:02
For sure some of the negative commenters are just the usual de-rampers who have an agenda to talk the SP down even farther to maximize their swing trades and wishing for 14p or whatever (or to suit their CFD/shorts), and yes we all know too that there are also those that understandably simply want to vent their frustration over the disappointments of the last year. Encouragingly there were no real surprises in the RNS and clearly some investors had sold down ahead of the RNS as a precautionary measure and are re-buying after it alongside others who see the stock as technically in over-sold territory and still having potential. The disappointment in management (though FDA parochialism is also partly to blame) is naturally palpable given the events of the last year but objectively there is still genuine potential in the company for growth and for the stock to appreciate substantially, perhaps more so than many on Aim given the current low MCAP, the solid tech and the addressable markets. With that RNS out the way there is less immediate downside risk to the SP here and prima facie the balance swings to the upside and the SP has room to start to recover. (Like most here I've lost money on this stock over the last year and I am, of course, cautious about re-investing heavily, but I still believe that there may well be real opportunity in it and that it is worth holding some in a balanced portfolio).